Shukra Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

74.57

58.83

20.49

11.20

11.85

Operating profit

19.40

5.36

2.89

1.44

1.54

Interest

0.29

0.28

0.29

0.03

-

Gross profit

21.93

6.28

2.68

1.77

1.55

EPS (Rs)

16.93

4.02

4.79

0.22

0.23

Other income

2.82

1.20

0.08

0.36

0.01

Stock adjustment

0.70

-0.33

-0.73

-0.19

-0.26

Raw material

13.38

11.35

11.08

2.95

3.33

Power and fuel

-

-

-

-

-

Employee expenses

5.65

4.89

4.90

4.07

4.40

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

35.44

37.56

2.35

2.93

2.84

Provisions made

-

-

-

-

-

Depreciation

2.05

1.84

1.66

1.47

1.48

Taxation

1.35

0.04

0.27

0.06

0.14

Net profit / loss

18.54

4.41

0.75

0.03

0.04

Extra ordinary item

-

-

-

-0.20

0.10

Prior year adjustments

-

-

-

-

-

Equity capital

10.95

10.96

1.57

1.57

1.57

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.02

9.12

14.09

12.90

13.00

GPM (%)

28.34

10.46

13.03

15.29

13.06

NPM (%)

23.95

7.34

3.65

0.29

0.30